New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Press Release (8)

3 min read

AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics’ Newly Approved Libmeldy™

January 4, 2021 at 6:30 AM
Press Release
Read press release

2 min read

Pierre Fabre Selects AGC Biologics as CDMO to Manufacture the Orphan Drug ER-004

December 21, 2020 at 7:00 AM
Press Release
Read press release

1 min read

AGC Biologics to Expand Biopharmaceutical CDMO Capacity

November 30, 2020 at 3:10 PM
Press Release
Read press release

2 min read

AGC Biologics and Horizon Therapeutics plc Expand Partnership

October 29, 2020 at 12:00 PM
Press Release
Read press release

1 min read

MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition

October 27, 2020 at 4:00 PM
Press Release
Read press release

2 min read

AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions

October 15, 2020 at 5:00 AM
Press Release
Read press release

2 min read

AGC Biologics Appoints Luca Alberici as the New General Manager/Site Head of the Milan, Italy Site

October 12, 2020 at 5:00 AM
Press Release
Read press release

2 min read

AGC Biologics Completes PPQ Manufacturing with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab

August 25, 2020 at 7:00 AM
Press Release
Read press release

1 min read

AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage

August 13, 2020 at 6:00 AM
Press Release
Read press release

2 min read

AGC Biologics Expands Partnership with Novavax

August 10, 2020 at 1:05 PM
Press Release
Read press release
Prev 6 7 8 9 10 Next